MDMA stock price forecast: Analyst targets & price scenarios
How will MDMA stock perform in 2026 and 2030?
This page primarily displays the projected price range for MDMA stock over the next 12 months, as well as trading recommendations for the next three months. This data is based on the historical performance of MDMA, the development trends of PharmAla Biotech Holdings, Inc., and a summary of analysis reports from major international investment banks and Wall Street research institutions, along with price analyses and forecasts from well-known analysts on platforms such as TradingView and Reddit. Together, these sources form a comprehensive market outlook for MDMA. The forecast includes potential high, median, and low price scenarios to help users understand possible future price movements across different time horizons.
This page combines PharmAla Biotech Holdings, Inc.'s financial performance and industry trends to provide short-term price predictions for MDMA stock over the next one to two years, as well as long-term price predictions extending to 2030.
The data is updated regularly as new market information becomes available. The information on this page is for reference only and does not constitute investment advice.
1-year MDMA stock price forecast
As of 2026-07-04, the median 12-month price target for MDMA, based on forecasts from global investment institutions and analysts, including those on Wall Street, is 0.19 CAD. This forecast is available on the Bitget website and is updated regularly.
Analyst rating for MDMA
Based on ratings from 26 analysts over the past three months, the overall consensus is Hold.
Based on Bitget's statistics as of 2026-07-04, analyst ratings for MDMA stock over the past three months are: 54% Buy, 0% Hold, and 46% Sell. All data comes from reports by major financial institutions and analysts. The data is updated regularly as new market information becomes available. The information on this page is for reference only and does not constitute investment advice.
Bitget ushers in the Stocks 2.0 era:
A new way to trade stocks — anytime, anywhere, 24/7.
Access Wall Street liquidity, dividend payouts, and futures margin support.
Key differences between Bitget and traditional brokers
What are the key advantages of Bitget Stocks 2.0?
1. Access real U.S. stock market depth with fast, low-latency trading.
2. Trade stocks backed 1:1 by real underlying assets, with dividends credited directly to your account.
3. Use your stock assets across Bitget's margin and yield ecosystem.
How do I start stock trading on Bitget?
1. Create an account and complete identity verification.
2. Deposit USDT into your spot account.
3. Go to the stock trading section.
4. Place trades and manage your positions.
Trending spot stocks
FAQ
How has MDMA's EPS performed recently?
What is the revenue forecast for MDMA next quarter?
What is the price target for MDMA?
What is the analyst rating for MDMA?
Is MDMA stock a good buy right now?
What is the MDMA stock price target for 2027?
What is the projected price of MDMA stock in 2030?
Can I buy MDMA stock on Bitget?
How do I buy MDMA stock on Bitget?
2. Deposit USDT into your spot account using fiat payment methods, on-chain transfers, or other supported options.
3. On the trading page, switch to the Stocks Spot tab. Search for the stock you want to trade (e.g., MDMA) to open the MDMA trading page.
4. Enter the order quantity, confirm your order, and the trade will be executed in milliseconds.
MDMA stock chart
MDMA stock detailsMDMA stock price change
On the last trading day, MDMA stock closed at 0.14 CAD, with a price change of -3.45% for the day.
Trade spot stocks (24/7)Trade stock perps (up to 100x leverage)